See the DrugPatentWatch profile for Trabectedin
When does trabectedin’s patent expire in the EU?
The provided information does not include the specific trabectedin patent(s) or their jurisdiction-by-jurisdiction expiry dates in the European Union (EU). Patent end dates can also differ depending on which compound/patent family, country filings, and any supplemental protection mechanisms apply.
To pin down the EU expiry date, you would need at least one of the following: the INN/trade name the patents cover, the relevant patent numbers (or the patent family), or the marketing authorisation holder/product in the EU for which exclusivity is being assessed.
When does trabectedin’s patent expire in the US?
The provided information does not include the specific trabectedin patent(s) or the relevant US expiry dates. In the US, patent “expiry” can refer to the expiration of a granted patent, and drug exclusivity can also be affected by periods of exclusivity and any patent term adjustments.
Getting an accurate US date requires the relevant US patent number(s) or patent family details tied to trabectedin and the specific product.
When does trabectedin’s patent expire in India?
The provided information does not include the specific trabectedin patent(s) or their expiry dates in India. Like other jurisdictions, India’s “expiry” depends on the exact patent filings (and whether different claims/patent numbers cover the drug substance vs. formulations).
An accurate Indian date requires the patent number(s) for the trabectedin claims being evaluated.
What matters more than a single “patent expiry” date?
In each region, the effective time when generics/biosimilars or competitors can launch can depend on more than the earliest patent end date, such as:
- Which patent(s) in the family still have enforceable claims.
- Whether any extension-type mechanisms apply (jurisdiction-specific).
- Whether regulators grant and enforce exclusivity periods beyond patent expiry.
Because the underlying patent set is not provided here, any exact EU/US/India dates would be speculative.
What you can send to get exact EU/US/India expiry dates
If you share any one of the following, the expiry timelines can be stated precisely:
- A link or identifiers for the trabectedin product and patent family, or
- The relevant patent numbers for EU/US/India, or
- The marketing authorization holder and the country you’re tracking (and whether you mean drug-substance patents, formulation patents, or both).
Sources
No sources were provided in the prompt, so no jurisdiction-specific expiry data can be cited.